These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

78 related items for PubMed ID: 7910213

  • 1. Neuroprotective effects of a use-dependent blocker of voltage-dependent sodium channels, BW619C89, in rat middle cerebral artery occlusion.
    Graham SH, Chen J, Lan J, Leach MJ, Simon RP.
    J Pharmacol Exp Ther; 1994 May; 269(2):854-9. PubMed ID: 7910213
    [Abstract] [Full Text] [Related]

  • 2. Limiting ischemic injury by inhibition of excitatory amino acid release.
    Graham SH, Chen J, Sharp FR, Simon RP.
    J Cereb Blood Flow Metab; 1993 Jan; 13(1):88-97. PubMed ID: 8093250
    [Abstract] [Full Text] [Related]

  • 3. Cerebroprotective effect of BW619C89 after focal or global cerebral ischaemia in the rat.
    Smith SE, Lekieffre D, Sowinski P, Meldrum BS.
    Neuroreport; 1993 Sep 30; 4(12):1339-42. PubMed ID: 7903166
    [Abstract] [Full Text] [Related]

  • 4. BW619C89, a glutamate release inhibitor, protects against focal cerebral ischemic damage.
    Leach MJ, Swan JH, Eisenthal D, Dopson M, Nobbs M.
    Stroke; 1993 Jul 30; 24(7):1063-7. PubMed ID: 8100654
    [Abstract] [Full Text] [Related]

  • 5. Sodium channel blocking activity of AM-36 and sipatrigine (BW619C89): in vitro and in vivo evidence.
    Callaway JK, Castillo-Melendez M, Giardina SF, Krstew EK, Beart PM, Jarrott B.
    Neuropharmacology; 2004 Jul 30; 47(1):146-55. PubMed ID: 15165842
    [Abstract] [Full Text] [Related]

  • 6. Long-term beneficial effects of BW619C89 on neurological deficit, cognitive deficit and brain damage after middle cerebral artery occlusion in the rat.
    Smith SE, Hodges H, Sowinski P, Man CM, Leach MJ, Sinden JD, Gray JA, Meldrum BS.
    Neuroscience; 1997 Apr 30; 77(4):1123-35. PubMed ID: 9130792
    [Abstract] [Full Text] [Related]

  • 7. Effective plasma concentration of a novel Na+/Ca2+ channel blocker NS-7 for its cerebroprotective actions in rats with a transient middle cerebral artery occlusion.
    Aoki Y, Tamura M, Itoh Y, Seto T, Nonaka K, Mukai H, Ukai Y.
    J Pharmacol Exp Ther; 2001 Feb 30; 296(2):306-11. PubMed ID: 11160611
    [Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. Changes in amino acid neurotransmitters and cerebral blood flow in the ischemic penumbral region following middle cerebral artery occlusion in the rat: correlation with histopathology.
    Takagi K, Ginsberg MD, Globus MY, Dietrich WD, Martinez E, Kraydieh S, Busto R.
    J Cereb Blood Flow Metab; 1993 Jul 30; 13(4):575-85. PubMed ID: 8100237
    [Abstract] [Full Text] [Related]

  • 10. Effects of isradipine, an L-type calcium channel blocker on permanent and transient focal cerebral ischemia in spontaneously hypertensive rats.
    Campbell CA, Mackay KB, Patel S, King PD, Stretton JL, Hadingham SJ, Hamilton TC.
    Exp Neurol; 1997 Nov 30; 148(1):45-50. PubMed ID: 9398449
    [Abstract] [Full Text] [Related]

  • 11. Glutamate preconditioning prevents neuronal death induced by combined oxygen-glucose deprivation in cultured cortical neurons.
    Lin CH, Chen PS, Gean PW.
    Eur J Pharmacol; 2008 Jul 28; 589(1-3):85-93. PubMed ID: 18589412
    [Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. SB 234551 selective ET(A) receptor antagonism: perfusion/diffusion MRI used to define treatable stroke model, time to treatment and mechanism of protection.
    Legos JJ, Lenhard SC, Haimbach RE, Schaeffer TR, Bentley RG, McVey MJ, Chandra S, Irving EA, Andrew A Parsons, Barone FC.
    Exp Neurol; 2008 Jul 28; 212(1):53-62. PubMed ID: 18462720
    [Abstract] [Full Text] [Related]

  • 14. Reduction of cerebral infarct size by non-competitive AMPA antagonists in rats subjected to permanent and transient focal ischemia.
    Matucz E, Móricz K, Gigler G, Simó A, Barkóczy J, Lévay G, Hársing LG, Szénási G.
    Brain Res; 2004 Sep 03; 1019(1-2):210-6. PubMed ID: 15306255
    [Abstract] [Full Text] [Related]

  • 15. Mexiletine and magnesium independently, but not combined, protect against permanent focal cerebral ischemia in Wistar rats.
    Lee EJ, Ayoub IA, Harris FB, Hassan M, Ogilvy CS, Maynard KI.
    J Neurosci Res; 1999 Nov 01; 58(3):442-8. PubMed ID: 10518118
    [Abstract] [Full Text] [Related]

  • 16. DNA fragmentation and HSP70 protein induction in hippocampus and cortex occurs in separate neurons following permanent middle cerebral artery occlusions.
    States BA, Honkaniemi J, Weinstein PR, Sharp FR.
    J Cereb Blood Flow Metab; 1996 Nov 01; 16(6):1165-75. PubMed ID: 8898689
    [Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. Neuroprotection afforded by prior citicoline administration in experimental brain ischemia: effects on glutamate transport.
    Hurtado O, Moro MA, Cárdenas A, Sánchez V, Fernández-Tomé P, Leza JC, Lorenzo P, Secades JJ, Lozano R, Dávalos A, Castillo J, Lizasoain I.
    Neurobiol Dis; 2005 Mar 01; 18(2):336-45. PubMed ID: 15686962
    [Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. Neuroprotective effects of KCL-440, a new poly(ADP-ribose) polymerase inhibitor, in the rat middle cerebral artery occlusion model.
    Ikeda Y, Hokamura K, Kawai T, Ishiyama J, Ishikawa K, Anraku T, Uno T, Umemura K.
    Brain Res; 2005 Oct 26; 1060(1-2):73-80. PubMed ID: 16202986
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 4.